Skip to Main

Search

Results 861 to 870 of 1,016 for ""

Experimental drug makes radiation therapy more effective, less damaging: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/avasopasem-manganese.html

An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused by radiation therapy for cancer also appears to enhance radiation’s capacity to kill tumors.

COVID-19 hospitalizations increase among unvaccinated pregnant women: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/covid-19-hospitalizations-pregnant-women.html

Unvaccinated pregnant women are increasingly being hospitalized with COVID-19 during a nationwide surge of the Delta variant, according to research from UT Southwestern Medical Center.

UTSW working to reprogram cells to strengthen immunity in geriatric patients: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/reprogramming-cells.html

What if the key to aging well lies in reprogramming immune system cells to strengthen them against infections and cancer? Researchers at UT Southwestern are working to find out.

UTSW study finds Hispanic people receive lower-quality thrombectomies than white people: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/lower-quality-thrombectomies.html

A study by UT Southwestern neurology researchers found that Hispanic people have lower-quality outcomes than white people among ischemic stroke patients who receive endovascular thrombectomies. Racial disparities were not found between Black and white patients.

Study finds no danger of second COVID shot in those with allergic reactions to first dose: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/second-covid-shot.html

People who had a potentially allergic reaction to their first messenger RNA COVID-19 vaccination can safely receive their second shot, according to a study of patients conducted at several medical centers, including UT Southwestern.

Researchers find immune component to rare neurodegenerative disease : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/neurodegenerative-disease.html

UT Southwestern researchers have identified an immune protein tied to the rare neurodegenerative condition known as Niemann-Pick disease type C.

UT Southwestern scientists closing in on map of the mammalian immune system: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/mammalian-immune-system.html

Using artificial intelligence, UT Southwestern scientists have identified thousands of genetic mutations likely to affect the immune system in mice. The work is part of one Nobel laureate’s quest to find virtually all such variations in mammals.

UTSW-led research identifies new imaging biomarkers that predict antidepressant response : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/new-imaging-biomarkers.html

Research led by UT Southwestern has identified MRI brain imaging biomarkers that bring new levels of precision for prescribing the most effective antidepressants.

National Cancer Institute renews Simmons Cancer Center’s prestigious comprehensive designation: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/nci-renews-scc.html

The National Cancer Institute has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation, reaffirming its place among the country’s elite cancer institutes.

New NIH grant supports ongoing UTSW investigation of debilitating complications of blood clots in teens: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/blood-clots-in-teens.html

UT Southwestern will lead a multicenter investigation into why children and young adults experience decreased physical activity and shortness of breath after experiencing blood clots, thanks to a four-year $2.97 million grant from the National Institutes of Health (NIH).